Conference Reports for NATAP
EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom April 9-13
Back
Tweet
HCV in India at EASL: IDUs, Burden, Limited Access
EASL:
High Burden of HCV & HIV/HCV Coinfection among Injection Drug Users in India: Need for Integration of HIV & HCV Services
- (04/28/14)
EASL:
High Burden of Fibrosis and Metabolic Cofactors in a Cohort of Predominantly Genotype 3-Infected Injection Drug Users in Southern India
- (05/01/14)
EASL:
Limited Access to HCV Testing and Treatment among Injection Drug Users across India
- (04/30/14)
EASL -
The International Liver Congress 2014 49th Annual Meeting of the European Association for the Study of the Liver
London, United Kingdom
April 9-13